FDA Inspection 1060256 — Chongqing Taihao Pharmaceutical Co., Ltd.
The FDA completed an inspection of Chongqing Taihao Pharmaceutical Co., Ltd. on May 10, 2018 in Jiulong Po District. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 10, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jiulong Po District (China)